The ambulatory infusion center market offers healthcare services to patients who need to receive ongoing medication, fluids or nutrients through an intravenous catheter or another vascular access device. These centers provide therapies like antibiotics, nutrition support, chemotherapy among others in an outpatient setting through skilled nursing care. The services offered are convenient and cost effective for patients as compared to traditional hospital-based infusions. Ambulatory infusion centers ensure optimal medication management and delivery of care in a comfortable environment.
The Global Ambulatory Infusion Center Market is estimated to be valued at US$ 67.84 Bn in 2024 and is expected to exhibit a CAGR of 9.6% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the ambulatory infusion center market are Option Care Health, PharmaScript, Cleveland Clinic, Stoughton Health, Coram CVS, Hattiesburg Clinic, UnitedHealth Group, UK HealthCare, CHI Health, PharMerica, Beacon Health System, Inc., Arnot Health, Inc. , IVX Health and Precision Healthcare. The rising prevalence of chronic diseases coupled with the growing geriatric population needing long term care are major factors driving the demand for ambulatory infusion services. Technological advancements in portable infusion pumps and networks supporting remote monitoring are enabling delivery of therapies outside of hospital settings in a cost effective manner.
Market Trends
Shift towards home healthcare - There is a growing preference for receiving medical treatments from the comfort of home rather than visiting hospitals or clinics. This is boosting investments by market players in telehealth and remote monitoring equipment supporting delivery of infusion therapies.
Outsourcing non-core services - Large healthcare providers are engaging third party service providers for functions like ambulatory infusion services to focus on their core clinical specialties. This is creating opportunities for standalone centers to partner with hospitals and clinics.
Market Opportunities
Oncology segment - Significant number of cancer patients requiring periodic chemotherapy presents a major opportunity for ambulatory infusion centers. With advancements in targeted drug therapies, infusion services are being delivered on an outpatient basis.
Value-based reimbursements - The transition towards value-based care models where payments are linked to quality and healthcare outcomes will encourage wider adoption of ambulatory infusion centers. This will help lower overall costs while improving patient experience and satisfaction.
Impact of COVID-19 on Ambulatory Infusion Center Market
The COVID-19 pandemic has significantly impacted the growth of the ambulatory infusion center market. During the initial lockdown phase, elective procedures and routine outpatient visits reduced significantly. This led to a decline in the demand for infusion services in ambulatory centers. However, as restrictions eased in some regions, the market has started recovering gradually. Post-COVID, the demand is expected to grow steadily as more number of patients prefer home-based and outpatient treatments over inpatient stays due to fear of viral transmission in hospitals.
Ambulatory infusion centers played a crucial role during the pandemic by offering continued infusion treatments while ensuring safety measures for preventing the spread of infection. These centers adopted strict protocols including screening of patients, maintaining social distancing, frequent sanitization, and use of PPE kits by staff. Telehealth services also supported the management of chronic conditions requiring infusions from homes, reducing physical visits. Furthermore, the pandemic highlighted the importance of decentralized healthcare models. This is anticipated to drive higher utilization of ambulatory infusion facilities going forward. Overall, the long-term growth outlook for this market remains positive with strategic emphasis on technology, value-based models, and safety.
The United States accounts for the largest share of the global ambulatory infusion center market in terms of value. This is attributed to factors such rising healthcare costs, growing prevalence of chronic diseases, increasing preference for home-based care, and well-developed outpatient service networks in the country. The Asia Pacific region is projected to observe the fastest growth during the forecast period owing to improving access to healthcare, raising health awareness, expanding medical insurance coverage, and growing geriatric population in many Asian nations. China, India and Japan will emerge as highly lucrative markets.
Europe also holds significant potential for ambulatory infusion centers driven by favorable regulations supporting out-of-hospital care models and efforts to reduce overcrowding in hospitals. Countries like Germany, United Kingdom, and France dominate the European market. Overall, demand is estimated to surge across both developing and developed global markets with increasing integration of technology and day-case treatments.
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement.
(LinkedIn- https://www.linkedin.com/in/priya-pandey-8417a8173/
